Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Company operates in three business segments. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products. In April and August 2010, it established two subsidiaries in Brazil and Korea. In March 2011, it established two subsidiaries in India and China. On September 30, 2011, the Company acquired 100% interests in Nycomed A/S. In our complete report available for purchase the company is compared to: Astellas Pharma Incorporated, Eisai Company Limited and Bristol-Myers Squibb Company.